A new class of metabolic therapy
MEPTIDE (Tirzepatide Injection) is a first-in-class dual GIP and GLP-1 receptor agonist developed for the management of Type 2 Diabetes Mellitus and Obesity/Overweight.
One weekly injection. Two powerful pathways.
Unlike conventional GLP-1 receptor agonists, Tirzepatide activates both Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. This dual mechanism results in superior glucose lowering and greater weight reduction.
Product Description
MEPTIDE® contains Tirzepatide, a first-in-class dual GIP and GLP-1 receptor agonist developed for the management of Type 2 Diabetes Mellitus and Obesity/Overweight. Meptide improves glycemic control while producing clinically meaningful and sustained weight reduction through complementary metabolic pathways.
Composition, class & indications
Composition
- Active ingredient: Tirzepatide
- Strengths: 2.5mg, 5mg, 7.5mg, 10mg per 0.5mL
- Single-dose disposable prefilled injection pen
Therapeutic Class
- Dual GIP/GLP-1 Receptor Agonist
- Antidiabetic Agent
- Anti-Obesity Therapy
Indications
- Type 2 Diabetes Mellitus — improves glycemic control in adults
- Chronic weight management in adults with obesity or overweight with weight-related comorbidities
- Adjunct to diet and exercise
Clinical Pharmacology
- Improves fasting plasma glucose
- Reduces postprandial glucose excursions
- Lowers HbA1c
- Promotes fat mass reduction while preserving lean body mass
- Improves beta-cell function and insulin sensitivity
Complementary metabolic pathways
MEPTIDE activates both GIP and GLP-1 receptors, leading to a cascade of beneficial metabolic effects.
Glucose-dependent insulin secretion
Reduced glucagon release
Delayed gastric emptying
Reduced appetite
Increased satiety
Reduced caloric intake
Improved insulin sensitivity
Significant body weight reduction
Take the First Step Toward a Healthier Future
MEPTIDE is a prescription medicine. Talk to your doctor to determine whether Tirzepatide is appropriate for your glycemic control and weight-management goals.
Individual results vary. Always follow your healthcare provider's guidance.
